268 related articles for article (PubMed ID: 6427468)
1. Soluble factor(s) released by Concanavalin A activated lymph node lymphocytes induce proliferation and maturation of chronic lymphocytic leukaemia (CLL) B lymphocytes.
Matera L; Massaia M; Pegoraro L
J Clin Lab Immunol; 1984 Feb; 13(2):85-8. PubMed ID: 6427468
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
3. Developmental changes in humoral suppressor activity released from concanavalin A-stimulated human lymphocytes on B cell differentiation.
Miyawaki T; Kubo M; Nagaoki T; Moriya N; Yokoi T; Mukai M; Taniguchi N
J Immunol; 1981 May; 126(5):1720-3. PubMed ID: 6452476
[TBL] [Abstract][Full Text] [Related]
4. Interindividual phenotypic variations in CLL B lymphocyte maturation indication of different maturation blocks.
Rozynkowa D; Antosz H; Rupniewska ZM; Kurowska M; Kulig A; Welcz B; Gorski G; Wojcierowski J
Acta Anthropogenet; 1985; 9(1-3):48-62. PubMed ID: 3939670
[TBL] [Abstract][Full Text] [Related]
5. Cell kinetics in chronic lymphocytic leukaemia (CLL).
Stryckmans PA; Debusscher L; Collard E
Clin Haematol; 1977 Feb; 6(1):159-67. PubMed ID: 334407
[TBL] [Abstract][Full Text] [Related]
6. PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.
Robert KH
Clin Exp Immunol; 1979 Sep; 37(3):517-22. PubMed ID: 315847
[TBL] [Abstract][Full Text] [Related]
7. Differentiation ability of the CLL lymphocyte: an immature lymphocyte or an abnormal leukemic cell?
Dighiero G; Bodega E; Binet JL
Blood Cells; 1981; 7(2):331-9. PubMed ID: 6975143
[TBL] [Abstract][Full Text] [Related]
8. Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin.
Maino VC; Kurnick JT; Kubo RT; Grey HM
J Immunol; 1977 Mar; 118(3):742-8. PubMed ID: 403235
[TBL] [Abstract][Full Text] [Related]
9. Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia.
Kettman JR; Smith RG; Uhr JW; Vitetta ES; Sheehan R; Ligler FS; Frenkel EP
Blood Cells; 1983; 9(1):21-33. PubMed ID: 6407550
[TBL] [Abstract][Full Text] [Related]
10. T cells in B cell chronic lymphocytic leukaemia. I. Decreased frequency of T lymphocytes secreting suppressor factor.
Bloem AC; Clevers JC; Bast EJ; Ballieux RE
Clin Exp Immunol; 1986 Jan; 63(1):188-93. PubMed ID: 3485483
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
12. T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants.
Raulet DH; Hünig T; Parker DC
J Immunol; 1982 Feb; 128(2):908-12. PubMed ID: 6798126
[TBL] [Abstract][Full Text] [Related]
13. Mitogenic activity of a water-soluble adjuvant (Bu-WSA) obtained from Bacterionema matruchotii. IV. Synergistic effects of Bu-WSA on Concanavalin A-induced proliferative response of human peripheral blood lymphocytes.
Nitta T; Okumura S; Tsushi M; Nakano M
Microbiol Immunol; 1982; 26(7):585-97. PubMed ID: 6982390
[TBL] [Abstract][Full Text] [Related]
14. T-lymphocytes bearing Fc-receptors for IgG in B-cell chronic lymphocytic leukaemia.
Matolcsy A; Magyarlaki T; Baliko Z; Tornoczky J
Haematologia (Budap); 1985; 18(3):185-91. PubMed ID: 2941348
[TBL] [Abstract][Full Text] [Related]
15. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
16. J chain synthesis and ultrastructural changes in chronic lymphocytic leukaemia cells during in vitro differentiation.
Yasuda N; Shimada H; Kanoh T; Uchino H
Clin Exp Immunol; 1984 Aug; 57(2):351-7. PubMed ID: 6432382
[TBL] [Abstract][Full Text] [Related]
17. Reduced T lymphocyte colonies in B chronic lymphocytic leukaemia. III. Evidence of a proliferative abnormality of the T helper cell population.
Foa R; Lauria F
Clin Exp Immunol; 1982 Nov; 50(2):336-40. PubMed ID: 6217934
[TBL] [Abstract][Full Text] [Related]
18. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of chronic lymphatic leukaemia cells by pokeweed mitogen after treatment with neuraminidase-galactose oxidase.
Zafar MN; Pittman S; Cherchi M; Catovsky D
Clin Exp Immunol; 1981 Apr; 44(1):124-8. PubMed ID: 6973427
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mouse cells releasing or responding to mitogenic factor induced by phytomitogens in vitro.
Jacobsson H; Blomgren H
J Immunol; 1975 May; 114(5):1631-7. PubMed ID: 1079042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
